Search

​On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...

Decision Time: Second Circuit Allows Controversial Nonconsensual Third-Party Releases in Purdue Pharma Chapter 11 Plan Join a distinguished panel of lawyers and law professors as they discuss the Second Circuit’s important Purdue Pharma decision. Whether you want to learn more about the circuit’s...

Mediating Bankruptcy Disputes: A Ghost-Runner on Second or Need a New Game? Bankruptcy practice relies on mediation from preferences to chapter 11 plan formulation and confirmation, and many other claims and litigation disputes in a wide variety of settings, including appeals. The use and practice...

The much-anticipated Stakeholders’ call took place on April 25th. As expected, there was not a lot of detailed direction provided although it was acknowledged that to the extent questions were not answered USCIS would try to otherwise address the questions at a later point in time. The following...

Leading Change in the Profession & the Community: Shaping the Future Monique Bair DiSabatino will appear on a panel during the 14th Annual Philadelphia Credit & Restructuring Summit at The Union league of Philadelphia.

The EB-5 Reform and Integrity Act of 2022 (“RIA”) notes that “[a]n alien seeking to pool his or her investment with 1 or more additional aliens seeking classification under section 203(b)(5) shall file for such classification in accordance with section 203(b)(5)(E), or before the date of the...

Partners Rohit Kapuria and Ronald Fieldstone will speak during the 2023 EB-5 & Global Immigration Expo in Miami. The expo will offer high-quality education from industry leaders and will feature interactive panels moderated by experienced immigration and global migration professionals. The panels...